CMS CAMERON MCKENNA NABARRO OLSWANG LLP
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Theatrical Producers (Except Motion Picture) and Miscellaneous Theatrical Services, Health and Allied Services, Not Elsewhere Classified, Legal Services, Individual and Family Social Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about CMS CAMERON MCKENNA NABARRO OLSWANG LLP
Live alerts from global media, monitored by Business Radar
2024-12-02 (artificiallawyer.com)
Noxtua Europes First Sovereign Legal AI Partners With ClauseBase
Noxtua, which is described by its developer Xayn as ‘Europe’s first sovereign Legal AI’ – and backed by law firm CMS – is partnering with contract automation and drafting company ClauseBase to prov…
Read more
2024-10-31 (cdr-news.com)
Maciver moves to CMS in Edinburgh
A former Burness Paull partner with over two decades’ construction disputes, regulatory and policy experience is CMS’ latest partner hire in the Scottish capital.
Read more
2024-10-03 (fraserofallander.org)
Skills for Today and Tomorrow
At the start of 2024, international law firm CMS teamed up with the Fraser of Allander Institute on a thought leadership campaign, under the theme ‘Skills for Today and Tomorrow’.
Read more
2024-10-03 (fraserofallander.org)
Skills for Today and Tomorrow
At the start of 2024, international law firm CMS teamed up with the Fraser of Allander Institute on a thought leadership campaign, under the theme ‘Skills for Today and Tomorrow’.
Read more
2024-09-17 (pharmaphorum.com)
The critical importance of payer-provider collaboration goes beyond prior authorisation
This article discusses the critical importance of payer-provider collaboration in the Medicare system, highlighting its impact beyond prior authorisation processes. Learn more about how collaboration between payers and providers can improve patient outcomes and streamline healthcare delivery.
Read more
2024-09-16 (alphagalileo.org)
Professor Costas Fountas elected as next President of the CERN Council
The CERN Council has announced that Professor Costas Fountas will become its 25th President beginning on 1 January 2025
Read more
2024-08-07 (investing.com)
Earnings call: Jacobs Solutions announces strategic shifts, shares repurchase By Investing.com
Earnings call: Jacobs Solutions announces strategic shifts, shares repurchase
Read more
2024-07-25 (scottishfinancialnews.com)
CMS names green energy expert as latest Aberdeen partner
Vini Cowden, an energy specialist lawyer focused on electricity transmission, carbon capture and storage, and offshore wind, has become the latest partner to CMS’s Aberdeen office. She relocates to the Granite City from Glasgow where she has been based since joining CMS in 2001.
Read more
2024-05-11 (highgrowth.scot)
CMS announces partner promotion in Scotland, further strengthening ICE Disputes practice
CMS has announced the promotion of Laura West to partner in its Infrastructure, Construction and Energy Disputes (ICE Disputes) practice. Based in the firm’ s Edinburgh office, Laura helps clients to resolve complex, high value disputes providing strategic contract advice as well as advising when
Read more
2024-02-05 (businesswire.com)
Vertex Reports Fourth Quarter and Full Year 2023 Financial Results
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and full year ended December 3
Read more
2024-02-05 (businesswire.com)
Vertex Reports Fourth Quarter and Full Year 2023 Financial Results
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and full year ended December 3
Read more
2023-11-30 (scottishlegal.com)
Aberdeen project to explore landscape of digital legal assets
Digital assets and the legal framework surrounding them will be the focus of a new research project funded by the Royal Society of Edinburgh (RSE). A team from the University of Aberdeen’s Centre for Commercial Law consisting of Dr Burcu Yüksel Ripley, Dr Alisdair MacPherson and Luci Care
Read more